Annual FCF
-$334.77 M
+$3.99 M+1.18%
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual free cash flow is currently -$334.77 million, with the most recent change of +$3.99 million (+1.18%) on 31 December 2023. During the last 3 years, it has fallen by -$256.12 million (-325.63%). BHVN annual FCF is now -5848.35% below its all-time high of -$5.63 million, reached on 31 December 2015.BHVN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$141.89 M
+$28.86 M+16.90%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly free cash flow is currently -$141.89 million, with the most recent change of +$28.86 million (+16.90%) on 30 September 2024. Over the past year, it has dropped by -$45.83 million (-47.71%). BHVN quarterly FCF is now -9083.62% below its all-time high of -$1.54 million, reached on 01 March 2016.BHVN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$531.06 M
-$45.83 M-9.44%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding TTM free cash flow is currently -$531.06 million, with the most recent change of -$45.83 million (-9.44%) on 30 September 2024. Over the past year, it has dropped by -$235.93 million (-79.94%). BHVN TTM FCF is now -34272.94% below its all-time high of -$1.54 million, reached on 01 March 2016.BHVN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.2% | -47.7% | -79.9% |
| 3 y3 years | -325.6% | - | - |
| 5 y5 years | -66.3% | -38.3% | -39.3% |
BHVN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -325.6% | +1.2% | -215.4% | +16.9% | -798.9% | at low |
| 5 y | 5 years | -325.6% | +12.2% | -215.4% | +33.4% | -798.9% | +29.0% |
| alltime | all time | -5848.4% | +12.2% | -9083.6% | +33.4% | <-9999.0% | +29.0% |
Biohaven Pharmaceutical Holding Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$141.89 M(-16.9%) | -$531.06 M(+9.4%) |
| June 2024 | - | -$170.75 M(+65.6%) | -$485.24 M(+35.0%) |
| Mar 2024 | - | -$103.08 M(-10.6%) | -$359.48 M(+7.4%) |
| Dec 2023 | -$334.77 M(-1.2%) | -$115.35 M(+20.1%) | -$334.77 M(+13.4%) |
| Sept 2023 | - | -$96.06 M(+113.5%) | -$295.13 M(-1.3%) |
| June 2023 | - | -$44.99 M(-42.6%) | -$299.15 M(-16.5%) |
| Mar 2023 | - | -$78.37 M(+3.5%) | -$358.05 M(+5.7%) |
| Dec 2022 | -$338.76 M(+130.8%) | -$75.71 M(-24.4%) | -$338.76 M(+28.8%) |
| Sept 2022 | - | -$100.08 M(-3.7%) | -$263.06 M(+61.4%) |
| June 2022 | - | -$103.89 M(+75.8%) | -$162.97 M(+175.8%) |
| Mar 2022 | - | -$59.08 M(-72.3%) | -$59.08 M(-92.1%) |
| Dec 2021 | -$146.78 M(+86.6%) | - | - |
| Dec 2020 | -$78.65 M(-79.4%) | - | - |
| Dec 2020 | - | -$213.11 M(+15.7%) | -$748.35 M(+17.3%) |
| Sept 2020 | - | -$184.23 M(+4.1%) | -$637.84 M(+21.7%) |
| June 2020 | - | -$176.93 M(+1.6%) | -$523.93 M(+3.3%) |
| Mar 2020 | - | -$174.09 M(+69.7%) | -$507.30 M(+33.1%) |
| Dec 2019 | -$381.12 M | - | - |
| Dec 2019 | - | -$102.59 M(+45.9%) | -$381.12 M(+21.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$70.32 M(-56.1%) | -$313.47 M(+7.0%) |
| June 2019 | - | -$160.30 M(+234.6%) | -$293.02 M(+75.1%) |
| Mar 2019 | - | -$47.91 M(+37.1%) | -$167.32 M(-16.9%) |
| Dec 2018 | -$201.31 M(+111.1%) | - | - |
| Dec 2018 | - | -$34.95 M(-29.9%) | -$201.31 M(-2.9%) |
| Sept 2018 | - | -$49.87 M(+44.1%) | -$207.41 M(+15.8%) |
| June 2018 | - | -$34.60 M(-57.7%) | -$179.09 M(+5.6%) |
| Mar 2018 | - | -$81.89 M(+99.5%) | -$169.57 M(+77.8%) |
| Dec 2017 | -$95.36 M(+222.9%) | - | - |
| Dec 2017 | - | -$41.05 M(+90.5%) | -$95.36 M(+35.5%) |
| Sept 2017 | - | -$21.55 M(-14.1%) | -$70.38 M(+22.4%) |
| June 2017 | - | -$25.08 M(+226.8%) | -$57.50 M(+61.2%) |
| Mar 2017 | - | -$7.67 M(-52.3%) | -$35.66 M(+20.8%) |
| Dec 2016 | -$29.53 M(+424.7%) | - | - |
| Dec 2016 | - | -$16.08 M(+85.4%) | -$29.53 M(+119.5%) |
| Sept 2016 | - | -$8.67 M(+167.6%) | -$13.45 M(+181.2%) |
| June 2016 | - | -$3.24 M(+109.7%) | -$4.79 M(+209.7%) |
| Mar 2016 | - | -$1.54 M | -$1.54 M |
| Dec 2015 | -$5.63 M | - | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual free cash flow?
- What is the all time high annual FCF for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual FCF year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly free cash flow?
- What is the all time high quarterly FCF for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly FCF year-on-year change?
- What is Biohaven Pharmaceutical Holding TTM free cash flow?
- What is the all time high TTM FCF for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding TTM FCF year-on-year change?
What is Biohaven Pharmaceutical Holding annual free cash flow?
The current annual FCF of BHVN is -$334.77 M
What is the all time high annual FCF for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual free cash flow is -$5.63 M
What is Biohaven Pharmaceutical Holding annual FCF year-on-year change?
Over the past year, BHVN annual free cash flow has changed by +$3.99 M (+1.18%)
What is Biohaven Pharmaceutical Holding quarterly free cash flow?
The current quarterly FCF of BHVN is -$141.89 M
What is the all time high quarterly FCF for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly free cash flow is -$1.54 M
What is Biohaven Pharmaceutical Holding quarterly FCF year-on-year change?
Over the past year, BHVN quarterly free cash flow has changed by -$45.83 M (-47.71%)
What is Biohaven Pharmaceutical Holding TTM free cash flow?
The current TTM FCF of BHVN is -$531.06 M
What is the all time high TTM FCF for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high TTM free cash flow is -$1.54 M
What is Biohaven Pharmaceutical Holding TTM FCF year-on-year change?
Over the past year, BHVN TTM free cash flow has changed by -$235.93 M (-79.94%)